Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume University School of Medicine, Fukuoka, Japan.
Clin Cardiol. 2011 Mar;34(3):189-94. doi: 10.1002/clc.20834. Epub 2011 Feb 17.
Monocyte chemoattractant protein-1 (MCP-1) plays a role in cardiovascular disease (CVD) and renal injury. Recent clinical studies have suggested that circulating levels of MCP-1 could be a biomarker of atherosclerosis and future cardiovascular events in humans. Because chronic kidney disease (CKD) is one of the risk factors of CVD, it is conceivable that elevated MCP-1 levels may link the increased risk of CVD in CKD patients. However, as far as we know, in addition to well-known traditional risk factors for atherosclerosis, whether renal dysfunction could be independently associated with the elevation of MCP-1 levels in a general population remains unknown. Therefore, we examined here which anthropometric and metabolic variables, including renal function, could be independent correlates of circulating levels of MCP-1 in a general population.
We hypothesized that renal function was one of the independent correlates of serum MCP-1 levels.
A total of 860 Japanese residents (318 males and 542 females, mean age 65.4 ± 9.8 years) in a small fishing community underwent a complete history and physical examination with determination of blood chemistries, including serum levels of MCP-1.
Mean MCP-1 levels were 281.4 pg/mL. Multiple stepwise regression analyses revealed that male sex (P<0.0001), age (P=0.03), estimated glomerular filtration rate (eGFR) (P<0.0001, inversely), and white blood cell count (P=0.037) were independently associated with MCP-1 levels.
The present study demonstrated for the first time that other than white blood cell count, eGFR was an independent correlate of serum levels of MCP-1 in a Japanese general population. Elevated MCP-1 levels may partly explain the increased risk of CVD in CKD patients.
单核细胞趋化蛋白-1(MCP-1)在心血管疾病(CVD)和肾损伤中发挥作用。最近的临床研究表明,循环 MCP-1 水平可能是人类动脉粥样硬化和未来心血管事件的生物标志物。由于慢性肾脏病(CKD)是 CVD 的危险因素之一,可以想象,升高的 MCP-1 水平可能与 CKD 患者 CVD 风险增加有关。然而,据我们所知,除了众所周知的动脉粥样硬化的传统危险因素外,肾功能是否可独立与一般人群中 MCP-1 水平的升高相关仍不清楚。因此,我们在此检查了哪些人体测量和代谢变量,包括肾功能,可与一般人群中循环 MCP-1 水平相关。
我们假设肾功能是血清 MCP-1 水平的独立相关因素之一。
一个小渔村的 860 名日本居民(318 名男性和 542 名女性,平均年龄 65.4±9.8 岁)接受了完整的病史和体格检查,并测定了血液化学物质,包括血清 MCP-1 水平。
平均 MCP-1 水平为 281.4 pg/mL。多元逐步回归分析显示,男性(P<0.0001)、年龄(P=0.03)、估计肾小球滤过率(eGFR)(P<0.0001,呈负相关)和白细胞计数(P=0.037)与 MCP-1 水平独立相关。
本研究首次证明,除白细胞计数外,eGFR 是日本一般人群血清 MCP-1 水平的独立相关因素。升高的 MCP-1 水平可能部分解释了 CKD 患者 CVD 风险增加的原因。